Core Scientific (CORZW) Amortization of Deferred Charges (2021 - 2026)

Core Scientific has reported Amortization of Deferred Charges for 6 years, with the latest figure at $3.2 million in Q2 2026.

• Quarterly Amortization of Deferred Charges rose 147.78% year-over-year to $3.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.7 million (up 31.74% YoY) and the FY2025 annual result came in at $11.3 million, up 62.9% from the prior year.
• Amortization of Deferred Charges grew to $3.2 million in Q2 2026 per CORZW's latest filing, from $3.2 million in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $3.2 million in Q2 2026 and troughed at $49000.0 in Q4 2023.
• A 5-year average of $1.6 million and a median of $1.3 million in 2025 frame the typical range for Amortization of Deferred Charges.
• The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges plunged 94.91% in 2023, then soared 6255.1% in 2024.
• Over 5 years, Amortization of Deferred Charges stood at $963000.0 in 2022, then slumped by 94.91% to $49000.0 in 2023, then jumped by 6255.1% to $3.1 million in 2024, then slipped by 3.08% to $3.0 million in 2025, then gained by 7.06% to $3.2 million in 2026.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $3.2 million, $3.2 million, and $3.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.